Allergy Therapeutics plc (AIM: AGY)

Allergy Therapeutics Revenue

Allergy Therapeutics had revenue of 33.57M GBP in the half year ending December 31, 2023, a decrease of -31.06%. This brings the company's revenue in the last twelve months to 53.26M, down -16.75% year-over-year. In the fiscal year ending June 30, 2023, Allergy Therapeutics had annual revenue of 59.59M, down -18.11%.

• Revenue (ttm): 53.26M
• Revenue Growth: -16.75%
• P/S Ratio: 1.37
• Revenue / Employee: 87.02K
• Employees: 612
• Market Cap: 204.96M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2023	59.59M	-13.18M	-18.11%
Jun 30, 2022	72.77M	-11.56M	-13.71%
Jun 30, 2021	84.33M	6.13M	7.83%
Jun 30, 2020	78.20M	4.49M	6.09%
Jun 30, 2019	73.72M	5.37M	7.86%